Device for nasal spray
Description
1. Device for nasal spray
The broken lines depict portions of the device for nasal spray that form no part of the claim.
Claims
The ornamental design for a device for nasal spray, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
| D308100 | May 22, 1990 | Bishop |
| D328643 | August 11, 1992 | Mitchell |
| D489819 | May 11, 2004 | Ford |
| D739933 | September 29, 2015 | Ettlin |
| D842457 | March 5, 2019 | Partsch, IV |
| D860435 | September 17, 2019 | Wang |
| D863548 | October 15, 2019 | Partsch, IV |
| D864380 | October 22, 2019 | Partsch, IV |
| D868962 | December 3, 2019 | Partsch, IV |
| D869644 | December 10, 2019 | Partsch, IV |
| D869645 | December 10, 2019 | Partsch, IV |
| D869646 | December 10, 2019 | Partsch, IV |
| D890330 | July 14, 2020 | Wang |
| D891611 | July 28, 2020 | Valentin |
| D903098 | November 24, 2020 | Tom |
| D954942 | June 14, 2022 | Lee |
| 20080220107 | September 11, 2008 | Akerman |
| 20170172974 | June 22, 2017 | Cagle |
| 20190255545 | August 22, 2019 | Hohmann |
- Business Wire. Aptar Pharma's Bidose Nasal Drug Delivery Device Approved by U.S. FDA for Breakthrough Treatment of Depression. Mar. 18, 2019. https://bwnews.pr/3eENI2I (Year: 2019).
Patent History
Patent number: D969992
Type: Grant
Filed: Dec 23, 2020
Date of Patent: Nov 15, 2022
Inventor: Diego Espinoza (Oissel)
Primary Examiner: Darcey E Gottschalk
Application Number: 35/511,123
Type: Grant
Filed: Dec 23, 2020
Date of Patent: Nov 15, 2022
Inventor: Diego Espinoza (Oissel)
Primary Examiner: Darcey E Gottschalk
Application Number: 35/511,123
Classifications
